19 hrs ago
Joseph McKillips of Abbott Named New Chairperson of NETS
McKillips replaces Sandra Lee, Director Worldwide Fleet Safety for Johnson & Johnson, following a successful two-year term.
Trending on the Topix Network
Tue Apr 22, 2014
The Motley Fool
Why Johnson & Johnson Is Outperforming the Dow
Given the general weakness among health care stocks of late, you might suspect that pharma companies have been some of the more problematic components of the Dow.
Thu Apr 17, 2014
Dallas Woman Awarded $1.2 Million, Mesh Called Defectively Designed
For the first time, a Texas jury has decided the pelvic mesh made by healthcare giant Johnson & Johnson was defectively designed .
Wed Apr 16, 2014
The Miami Herald
Smartphone apps to help patients take their meds
Several smartphone apps are available to help patients take their medications as prescribed.
Target Price Increases Abound For J&J, But Stock Slips
Johnson & Johnson was giving up some of Tuesday's gains , although analysts were largely upbeat about the company's better-than-expected first-quarter earnings report, as evidenced by a flurry of target price increases.
The Motley Fool
Johnson & Johnson's Earnings Report Impresses
Devices and Consumer continue to log disappointing results, but the higher-margin Pharma business is more than making up the difference.
Tue Apr 15, 2014
Twitter Buys Gnip to Monetize Data; Johnson & Johnson Beats...
Shares of Twitter closed up 11.38% on Tuesday with about 24.2 million shares traded.
TransCelerate recognizes training programs from Icon, Synteract
Industry group TransCelerate Biopharma has certified that training programs from CROs Icon and SynteractHCR meet minimum criteria for ICH's good clinical practice training.
Wall Street Caps Turbulent Day With Solid Gains
After a volatile trading session, U.S. equity markets posted solid gains on the back of strong earnings from Coca-Cola and Johnson & Johnson.
Midday Market Stats: Dow Jones Industrial Average Stumbles on Mixed Economic News
The Dow Jones Industrial Average was earlier trying to extend Monday's positive momentum, and helping toward this goal were Dow components The Coca-Cola Company and Johnson & Johnson , which remain in the black on well-received earnings reports.
The Globe and Mail
Johnson & Johnson tops forecasts, helped by new medicines
In this Jan. 24, 2011 photo, Johnson & Johnson Band-Aid products are displayed, in Montpelier, Vt.
Mon Apr 14, 2014
Investing Ahead of Earnings: Johnson & Johnson and Coca Cola
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Sun Apr 13, 2014
The Daily Record
Campaigners renew calls for end to mesh implant operations after US court says device is defective
AMERICAN victim wins A 750,000 compensation from drugs giant Johnson & Johnson in a case that could have a big impact on the civil actions for damages launched by 400 Scottish women against mesh makers and NHS Scotland.
Fri Apr 11, 2014
The Motley Fool
Here's What's Behind Puma's Crash
Alan Auerbach, the former CEO of Cougar Biotechnology -- the company that developed Johnson & Johnson 's widely successful Zytiga prostate cancer drug -- hopes he has another blockbuster potential drug on his hands at Puma Biotechnology Xeloda head to head against GlaxoSmithKline 's Tykerb and Xeloda.
Thu Apr 10, 2014
Law firm Mintz Levin expands intellectual property practice
William C. Geary III, Lisa Adams, and Christina Sperry have joined as members of Mintz Levin's Boston office, the firm said in a Thursday press release .
The Huffington Post
Nigel Barker: Learning From Strong Women
This post is part of the Global Moms Relay . Every time you share this post, Johnson & Johnson will donate $1 to help improve the health and well-being of moms and kids worldwide through MAMA , Shot@Life , and Girl Up .
Tue Apr 08, 2014
Janssen Settles 76 Topamax Cases in Philadelphia
Johnson & Johnson subsidiary Janssen Pharmaceuticals has settled 76 cases in which plaintiffs alleged that the anti-seizure drug Topamax, taken during pregnancy, caused birth defects, according to a Philadelphia court order.
Mon Apr 07, 2014
$1.2M to Woman Hurt by J&J Mesh Implant
A Dallas jury has ordered Johnson & Johnson to pay Linda Batiste, a 64-year-old woman injured by one of the company's pelvic mesh implants, $1.2 million in compensatory damages.
Fri Apr 04, 2014
Transvaginal Mesh Patient Awarded $1.2 Million in Ethicon Mesh Lawsuit, Announces Baron and Budd
The mesh patient, Linda Batiste, was awarded $1.2 million for suffering serious health issues from her transvaginal mesh implant.